| Dr. Mary L. (Nora) Disis | Director, Tumor Vaccine Group | University of Washington, Washington | Oncology, Immunotherapy | Investigates cancer immunotherapies, specifically the development of therapeutic vaccines for cancer. | NCT02759588 |
| Dr. Brian J. Druker | Director, Knight Cancer Institute | Oregon Health & Science University, Oregon | Oncology, Leukemia | Develops targeted therapies for leukemia and other cancers, known for his work on the drug imatinib. | NCT00038649 |
| Dr. Janko Nikolich-Žugich | Professor and Department Chair | University of Arizona College of Medicine, Arizona | Immunology, Aging | Studies the age-related changes in immune function and develops strategies to improve immune health in older adults. | NCT03377361 |
| Dr. Jay C. Shendure | Professor of Genome Sciences | University of Washington, Washington | Genomics, Genetics | Develops new genomic technologies and applies them to study human genetics and disease. | NCT03732820 |
| Dr. Richard S. Larson | Executive Vice Chancellor | University of New Mexico Health Sciences Center, New Mexico | Oncology, Hematology | Researches the molecular mechanisms of leukemia development and evaluates targeted therapies. | NCT01164163 |
